Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Minnesota companies speak out | Exploring IVL trends | Robotic cardiac surgery building momentum | Cannabis & patient outcomes
Tuesday, January 27, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Minnesota medtech companies call for ‘de-escalation’ after Alex Pretti’s death

Executives from two of the world’s largest medtech companies, Medtronic and Boston Scientific, are among the leaders calling for "state, local and federal officials to work together to find real solutions."

READ MORE >
Minnesota businesses
Share on Twitter Share on Facebook Share on Linkedin

Minnesota medtech companies call for ‘de-escalation’ after Alex Pretti’s death

Share on Twitter Share on Facebook Share on Linkedin
Minnesota businesses
Executives from two of the world’s largest medtech companies, Medtronic and Boston Scientific, are among the leaders calling for "state, local and federal officials to work together to find real solutions."
READ MORE >

Exploring major trends as IVL keeps evolving

Intravascular lithotripsy is expected to see even wider adoption when lower-profile catheters are introduced and device costs start to drop, explained Samin Sharma, MD.

READ MORE >
Advances in calcified coronary plaque modification are increasingly centered on intravascular lithotripsy (IVL) because the technology reduces complications such as vessel trauma and perforation associated with traditional high-pressure balloons or atherectomy techniques. Cardiovascular Business spoke with Samin K. Sharma, MD, director of the Mount Sinai Fuster Heart Hospital Cardiovascular Clinical Institute, recently about the advances in IVL. #IVL #TCT
Share on Twitter Share on Facebook Share on Linkedin

Exploring major trends as IVL keeps evolving

Share on Twitter Share on Facebook Share on Linkedin
Advances in calcified coronary plaque modification are increasingly centered on intravascular lithotripsy (IVL) because the technology reduces complications such as vessel trauma and perforation associated with traditional high-pressure balloons or atherectomy techniques. Cardiovascular Business spoke with Samin K. Sharma, MD, director of the Mount Sinai Fuster Heart Hospital Cardiovascular Clinical Institute, recently about the advances in IVL. #IVL #TCT
Intravascular lithotripsy is expected to see even wider adoption when lower-profile catheters are introduced and device costs start to drop, explained Samin Sharma, MD.
READ MORE >

Robotic cardiac surgery building momentum thanks to RAVR, other breakthroughs

The sky may be the limit for robotic cardiac surgery in 2026 and beyond.

READ MORE >
Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).
Share on Twitter Share on Facebook Share on Linkedin

Robotic cardiac surgery building momentum thanks to RAVR, other breakthroughs

Share on Twitter Share on Facebook Share on Linkedin
Robotic aortic valve replacement (RAVR) is a new minimally invasive treatment option for symptomatic severe aortic stenosis (AS) that uses advanced robotic surgical systems. It has already started gaining momentum as an alternative to both surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR).
The sky may be the limit for robotic cardiac surgery in 2026 and beyond.
READ MORE >

Heavy cannabis use may not impact heart surgery outcomes

Cannabis use has been linked to multiple cardiovascular risks, but less is known about how it may affect patients who undergo major cardiac surgery.

READ MORE >
cannabis weed marijuana heart health doctor cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Heavy cannabis use may not impact heart surgery outcomes

Share on Twitter Share on Facebook Share on Linkedin
cannabis weed marijuana heart health doctor cardiologist
Cannabis use has been linked to multiple cardiovascular risks, but less is known about how it may affect patients who undergo major cardiac surgery.
READ MORE >

Featured Articles

CVRx hopes new research will expand access to heart failure therapy

The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.

READ MORE >
Barostim Neo 2 CVRx heart failure nerve stimulator on display at HRS 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

CVRx hopes new research will expand access to heart failure therapy

Share on Twitter Share on Facebook Share on Linkedin
Barostim Neo 2 CVRx heart failure nerve stimulator on display at HRS 2023. Photo by Dave Fornell
The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.
READ MORE >

Vascular surgeon accused of double murder pleads not guilty

The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.

READ MORE >
The long legal saga of Richard Paulus, a Kentucky cardiologist accused of performing unnecessary cardiac procedures, appears to still be going strong in 2022 and might be reviewed by the Supreme Court. The New York state radiologist is facing 36 misdemeanor counts for secret sexual recording without consent, according to a story in the Boston Herald.
Share on Twitter Share on Facebook Share on Linkedin

Vascular surgeon accused of double murder pleads not guilty

Share on Twitter Share on Facebook Share on Linkedin
The long legal saga of Richard Paulus, a Kentucky cardiologist accused of performing unnecessary cardiac procedures, appears to still be going strong in 2022 and might be reviewed by the Supreme Court. The New York state radiologist is facing 36 misdemeanor counts for secret sexual recording without consent, according to a story in the Boston Herald.
The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.
READ MORE >

Medtronic’s newest all-in-one PFA catheter gains critical approval

The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind. 

READ MORE >
Medtronic has secured CE mark approval for its Affera Sphere-360 catheter,
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s newest all-in-one PFA catheter gains critical approval

Share on Twitter Share on Facebook Share on Linkedin
Medtronic has secured CE mark approval for its Affera Sphere-360 catheter,
The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind. 
READ MORE >

IVL competition heats up as Boston Scientific enters US market

Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.

READ MORE >
The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.
Share on Twitter Share on Facebook Share on Linkedin

IVL competition heats up as Boston Scientific enters US market

Share on Twitter Share on Facebook Share on Linkedin
The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
READ MORE >

Coming soon: First-in-human study of gene-modifying drug for hypercholesterolemia

Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.

READ MORE >
Gene editing software image from Scribe Therapeutics for its STX-1150 drug to treat LDL-C.
Share on Twitter Share on Facebook Share on Linkedin

Coming soon: First-in-human study of gene-modifying drug for hypercholesterolemia

Share on Twitter Share on Facebook Share on Linkedin
Gene editing software image from Scribe Therapeutics for its STX-1150 drug to treat LDL-C.
Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.
READ MORE >

In Case You Missed It

Aetna covers AI-powered coronary plaque assessments, joining other major insurers

This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider. 

READ MORE >
insurance
Share on Twitter Share on Facebook Share on Linkedin

Aetna covers AI-powered coronary plaque assessments, joining other major insurers

Share on Twitter Share on Facebook Share on Linkedin
insurance
This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider. 
READ MORE >

ASE president outlines need to lead on AI, sustain echo workforce

ASE President David Wiener, MD, discussed his goals for 2026 in a new video interview. "The imager who doesn't use artificial intelligence will be replaced by the imager who does,” he said.

READ MORE >
Video interview with ASE President David Weiner explains goals of society in 2026. #ASE
Share on Twitter Share on Facebook Share on Linkedin

ASE president outlines need to lead on AI, sustain echo workforce

Share on Twitter Share on Facebook Share on Linkedin
Video interview with ASE President David Weiner explains goals of society in 2026. #ASE
ASE President David Wiener, MD, discussed his goals for 2026 in a new video interview. "The imager who doesn't use artificial intelligence will be replaced by the imager who does,” he said.
READ MORE >

Drugmaker moves ahead with sublingual heart attack treatment after positive FDA meeting

Based on feedback from the FDA, Aspire Biopharma plans on completing a multicenter clinical trial and then seeking regulatory approval for its new high-dose sublingual aspirin therapy. 

READ MORE >
A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
Share on Twitter Share on Facebook Share on Linkedin

Drugmaker moves ahead with sublingual heart attack treatment after positive FDA meeting

Share on Twitter Share on Facebook Share on Linkedin
A heart attack is caused when one of the coronary arteries becomes blocked with a clot.
Based on feedback from the FDA, Aspire Biopharma plans on completing a multicenter clinical trial and then seeking regulatory approval for its new high-dose sublingual aspirin therapy. 
READ MORE >

In Other News

California man pleads guilty in $54M radiology and hospice care fraud scheme

Alex Alexsanian, 48, of Burbank, entered a plea to one count of money laundering conspiracy on Jan. 20, with the scam tied to Saint Gorge Radiology, located in Sylmar. 

READ MORE >
Medicare fraud
Share on Twitter Share on Facebook Share on Linkedin

California man pleads guilty in $54M radiology and hospice care fraud scheme

Share on Twitter Share on Facebook Share on Linkedin
Medicare fraud
Alex Alexsanian, 48, of Burbank, entered a plea to one count of money laundering conspiracy on Jan. 20, with the scam tied to Saint Gorge Radiology, located in Sylmar. 
READ MORE >

Fans and foes of medical debt relief | Heat on the Hill for payer CEOs | One and done with algorithmic care | and more briefings

Several states use taxpayer dollars to help struggling residents pay down medical debt. One is considered a leader of the movement—by critics as well as proponents. 

READ MORE >
Medical Debt
Share on Twitter Share on Facebook Share on Linkedin

Fans and foes of medical debt relief | Heat on the Hill for payer CEOs | One and done with algorithmic care | and more briefings

Share on Twitter Share on Facebook Share on Linkedin
Medical Debt
Several states use taxpayer dollars to help struggling residents pay down medical debt. One is considered a leader of the movement—by critics as well as proponents. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup